| A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | AA | AB | AC | AD | AE | AF | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | COMBINEDBrain | 2253 XY5D | TBRS Community | Female | 19 | Control | Sibling Control | DNMT3A | 10/13/2023 | CBB003428 0010 | 10/14/2023 | PBMC | 1.2 mL Cryovial | EDTA | 1 | mL | 2 | Cryostor | In | |||||||||||||
3 | COMBINEDBrain | 2253 XY5D | TBRS Community | Female | 19 | Control | Sibling Control | DNMT3A | 10/13/2023 | CBB003428 0011 | 10/14/2023 | PBMC | 1.2 mL Cryovial | EDTA | 1 | mL | 2 | Cryostor | In | |||||||||||||
4 | COMBINEDBrain | 2253 XY5D | TBRS Community | Female | 19 | Control | Sibling Control | DNMT3A | 10/13/2023 | CBB003428 0012 | 10/14/2023 | PBMC | 1.2 mL Cryovial | EDTA | 1 | mL | 2 | Cryostor | In | |||||||||||||
5 | COMBINEDBrain | 2253 XY5D | TBRS Community | Female | 19 | Control | Sibling Control | DNMT3A | 10/13/2023 | CBB003428 0013 | 10/14/2023 | PBMC | 1.2 mL Cryovial | EDTA | 1 | mL | 2 | Cryostor | In | |||||||||||||
6 | COMBINEDBrain | 2253 XY5D | TBRS Community | Female | 19 | Control | Sibling Control | DNMT3A | 10/13/2023 | CBB003428 0014 | 10/14/2023 | PBMC | 1.2 mL Cryovial | EDTA | 1 | mL | 2 | Cryostor | In | |||||||||||||
7 | COMBINEDBrain | 2253 XY5D | TBRS Community | Female | 19 | Control | Sibling Control | DNMT3A | 10/13/2023 | CBB003428 0015 | 10/14/2023 | PBMC | 1.2 mL Cryovial | EDTA | 1 | mL | 2 | Cryostor | In | |||||||||||||
8 | COMBINEDBrain | 2253 XY5D | TBRS Community | Female | 19 | Control | Sibling Control | DNMT3A | 10/13/2023 | CBB003428 0016 | 10/14/2023 | PBMC | 1.2 mL Cryovial | EDTA | 1 | mL | 1.91 | Cryostor | In | |||||||||||||
9 | COMBINEDBrain | 2253 XY5D | TBRS Community | Female | 19 | Control | Sibling Control | DNMT3A | 10/13/2023 | CBB006999 0000 | 10/14/2023 | Plasma | 2.0 mL Cryovial | EDTA | 2000 | µL | In | |||||||||||||||
10 | COMBINEDBrain | 2253 XY5D | TBRS Community | Female | 19 | Control | Sibling Control | DNMT3A | 10/13/2023 | CBB007000 0000 | 10/14/2023 | Plasma | 2.0 mL Cryovial | EDTA | 2000 | µL | In | |||||||||||||||
11 | COMBINEDBrain | 2253 XY5D | TBRS Community | Female | 19 | Control | Sibling Control | DNMT3A | 10/13/2023 | CBB007001 0000 | 10/14/2023 | Plasma | 2.0 mL Cryovial | EDTA | 550 | µL | In | |||||||||||||||
12 | COMBINEDBrain | 2253 XY5D | TBRS Community | Female | 19 | Control | Sibling Control | DNMT3A | 10/13/2023 | CBB007001 0100 | 7/24/2024 | Plasma | Matrix Plate Tube | EDTA | 55 | µL | In | |||||||||||||||
13 | COMBINEDBrain | 2253 XY5D | TBRS Community | Female | 19 | Control | Sibling Control | DNMT3A | 10/13/2023 | CBB007008 0000 | 10/14/2023 | Whole Blood | 2.0 mL Cryovial | EDTA | In | |||||||||||||||||
14 | COMBINEDBrain | 2253 XY5D | TBRS Community | Female | 19 | Control | Sibling Control | DNMT3A | 10/13/2023 | CBB007056 0000 | 10/14/2023 | Urine | 2.0 mL Cryovial | 2000 | µL | In | ||||||||||||||||
15 | COMBINEDBrain | 2253 XY5D | TBRS Community | Female | 19 | Control | Sibling Control | DNMT3A | 10/13/2023 | CBB007057 0000 | 10/14/2023 | Urine | 2.0 mL Cryovial | 2000 | µL | In | ||||||||||||||||
16 | COMBINEDBrain | 22YX 22WD | TBRS Community | Female | 49 | Control | Parent Control | DNMT3A | 03/20/2026 | 56752507094450 | 03/20/2026 | Saliva | Stabilizing alcohol | 2 | mL | |||||||||||||||||
19 | COMBINEDBrain | 2355 9E53 | TBRS Community | Male | 43 | Control | Parent Control | DNMT3A | 03/19/2026 | 56752507094386 | 03/19/2026 | Saliva | Stabilizing alcohol | 2 | mL | |||||||||||||||||
20 | COMBINEDBrain | 25QS N7WB | TBRS Community | Male | 35 | Control | Parent Control | DNMT3A | 03/19/2026 | 56752507094419 | 03/19/2026 | Saliva | Stabilizing alcohol | 2 | mL | |||||||||||||||||
22 | COMBINEDBrain | 279X USD6 | TBRS Community | Female | 10 | Tatton Brown Rahman Syndrome | c.1903C>T; p.R635W | DNMT3A | 03/19/2026 | AB035665 | 03/19/2026 | Plasma | K2/EDTA | 150 | ul | |||||||||||||||||
23 | COMBINEDBrain | 279X USD6 | TBRS Community | Female | 10 | Tatton Brown Rahman Syndrome | c.1903C>T; p.R635W | DNMT3A | 03/19/2026 | AB035666 | 03/19/2026 | Plasma | K2/EDTA | 250 | ul | |||||||||||||||||
24 | COMBINEDBrain | 279X USD6 | TBRS Community | Female | 10 | Tatton Brown Rahman Syndrome | c.1903C>T; p.R635W | DNMT3A | 03/19/2026 | AB035667 | 03/19/2026 | Plasma | K2/EDTA | 500 | ul | |||||||||||||||||
25 | COMBINEDBrain | 279X USD6 | TBRS Community | Female | 10 | Tatton Brown Rahman Syndrome | c.1903C>T; p.R635W | DNMT3A | 03/19/2026 | AB035668 | 03/19/2026 | Plasma | K2/EDTA | 500 | ul | |||||||||||||||||
26 | COMBINEDBrain | 279X USD6 | TBRS Community | Female | 10 | Tatton Brown Rahman Syndrome | c.1903C>T; p.R635W | DNMT3A | 03/19/2026 | AB035669 | 03/19/2026 | Plasma | K2/EDTA | 500 | ul | |||||||||||||||||
27 | COMBINEDBrain | 279X USD6 | TBRS Community | Female | 10 | Tatton Brown Rahman Syndrome | c.1903C>T; p.R635W | DNMT3A | 03/19/2026 | AB035670 | 03/19/2026 | Plasma | K2/EDTA | 500 | ul | |||||||||||||||||
28 | COMBINEDBrain | 279X USD6 | TBRS Community | Female | 10 | Tatton Brown Rahman Syndrome | c.1903C>T; p.R635W | DNMT3A | 03/19/2026 | AB035671 | 03/19/2026 | Plasma | K2/EDTA | 500 | ul | |||||||||||||||||
29 | COMBINEDBrain | 279X USD6 | TBRS Community | Female | 10 | Tatton Brown Rahman Syndrome | c.1903C>T; p.R635W | DNMT3A | 03/19/2026 | AB035672 | 03/19/2026 | Plasma | K2/EDTA | 500 | ul | |||||||||||||||||
30 | COMBINEDBrain | 279X USD6 | TBRS Community | Female | 10 | Tatton Brown Rahman Syndrome | c.1903C>T; p.R635W | DNMT3A | 03/19/2026 | AB035673 | 03/19/2026 | Plasma | K2/EDTA | 500 | ul | |||||||||||||||||
31 | COMBINEDBrain | 279X USD6 | TBRS Community | Female | 10 | Tatton Brown Rahman Syndrome | c.1903C>T; p.R635W | DNMT3A | 03/19/2026 | AB035674 | 03/19/2026 | Plasma | K2/EDTA | 500 | ul | |||||||||||||||||
32 | COMBINEDBrain | 279X USD6 | TBRS Community | Female | 10 | Tatton Brown Rahman Syndrome | c.1903C>T; p.R635W | DNMT3A | 03/19/2026 | AB035675 | 03/19/2026 | Plasma | K2/EDTA | 500 | ul | |||||||||||||||||
33 | COMBINEDBrain | 279X USD6 | TBRS Community | Female | 10 | Tatton Brown Rahman Syndrome | c.1903C>T; p.R635W | DNMT3A | 03/19/2026 | AB035676 | 03/19/2026 | Plasma | K2/EDTA | 500 | ul | |||||||||||||||||
34 | COMBINEDBrain | 279X USD6 | TBRS Community | Female | 10 | Tatton Brown Rahman Syndrome | c.1903C>T; p.R635W | DNMT3A | 03/19/2026 | AB035677 | 03/19/2026 | Plasma | K2/EDTA | 500 | ul | |||||||||||||||||
35 | COMBINEDBrain | 279X USD6 | TBRS Community | Female | 10 | Tatton Brown Rahman Syndrome | c.1903C>T; p.R635W | DNMT3A | 03/19/2026 | AB035678 | 03/19/2026 | Plasma | K2/EDTA | 300 | ul | |||||||||||||||||
36 | COMBINEDBrain | 279X USD6 | TBRS Community | Female | 10 | Tatton Brown Rahman Syndrome | c.1903C>T; p.R635W | DNMT3A | 03/19/2026 | AB034641 | 03/19/2026 | Urine | NA | 1000 | ul | |||||||||||||||||
37 | COMBINEDBrain | 279X USD6 | TBRS Community | Female | 10 | Tatton Brown Rahman Syndrome | c.1903C>T; p.R635W | DNMT3A | 03/19/2026 | AB034642 | 03/19/2026 | Urine | NA | 1000 | ul | |||||||||||||||||
38 | COMBINEDBrain | 279X USD6 | TBRS Community | Female | 10 | Tatton Brown Rahman Syndrome | c.1903C>T; p.R635W | DNMT3A | 03/19/2026 | AB034643 | 03/19/2026 | Urine | NA | 1000 | ul | |||||||||||||||||
39 | COMBINEDBrain | 279X USD6 | TBRS Community | Female | 10 | Tatton Brown Rahman Syndrome | c.1903C>T; p.R635W | DNMT3A | 03/19/2026 | AB034632 | 03/19/2026 | Whole Blood | K2/EDTA | 1000 | ul | |||||||||||||||||
40 | COMBINEDBrain | 279X USD6 | TBRS Community | Female | 10 | Tatton Brown Rahman Syndrome | c.1903C>T; p.R635W | DNMT3A | 03/19/2026 | AB034633 | 03/19/2026 | Whole Blood | K2/EDTA | 1000 | ul | |||||||||||||||||
41 | COMBINEDBrain | 279X USD6 | TBRS Community | Female | 10 | Tatton Brown Rahman Syndrome | c.1903C>T; p.R635W | DNMT3A | 03/19/2026 | AB034634 | 03/19/2026 | Whole Blood | K2/EDTA | 1000 | ul | |||||||||||||||||
42 | COMBINEDBrain | 279X USD6 | TBRS Community | Female | 10 | Tatton Brown Rahman Syndrome | c.1903C>T; p.R635W | DNMT3A | 03/20/2026 | 47260110200360 | 03/20/2026 | Saliva | Stabilizing alcohol | 2 | mL | |||||||||||||||||
43 | COMBINEDBrain | 29FR 9457 | TBRS Community | Caucasian | Female | 11 | Tatton Brown Rahman Syndrome | c.2207G>A; p. R736H | DNMT3A | 10/13/2023 | CBB003415 0011 | 10/14/2023 | PBMC | 1.2 mL Cryovial | EDTA | 1 | mL | 2 | Cryostor | In | ||||||||||||
44 | COMBINEDBrain | 29FR 9457 | TBRS Community | Caucasian | Female | 11 | Tatton Brown Rahman Syndrome | c.2207G>A; p. R736H | DNMT3A | 10/13/2023 | CBB003415 0012 | 10/14/2023 | PBMC | 1.2 mL Cryovial | EDTA | 0.4 | mL | 0.8 | Cryostor | In | ||||||||||||
46 | COMBINEDBrain | 29FR 9457 | TBRS Community | Caucasian | Female | 11 | Tatton Brown Rahman Syndrome | c.2207G>A; p. R736H | DNMT3A | 10/13/2023 | CBB004199 0000 | 10/14/2023 | Blood Spot Card | 2.0 mL Cryovial | None | 2 | Blood Spot | In | ||||||||||||||
47 | COMBINEDBrain | 29FR 9457 | TBRS Community | Caucasian | Female | 11 | Tatton Brown Rahman Syndrome | c.2207G>A; p. R736H | DNMT3A | 10/13/2023 | CBB004200 0000 | 10/14/2023 | Plasma | 2.0 mL Cryovial | EDTA | 250 | µL | In | ||||||||||||||
48 | COMBINEDBrain | 29FR 9457 | TBRS Community | Caucasian | Female | 11 | Tatton Brown Rahman Syndrome | c.2207G>A; p. R736H | DNMT3A | 10/13/2023 | CBB004200 0100 | 7/24/2024 | Plasma | Matrix Plate Tube | EDTA | 55 | µL | In | ||||||||||||||
49 | COMBINEDBrain | 29FR 9457 | TBRS Community | Caucasian | Female | 11 | Tatton Brown Rahman Syndrome | c.2207G>A; p. R736H | DNMT3A | 10/13/2023 | CBB004201 0000 | 10/14/2023 | Plasma | 2.0 mL Cryovial | EDTA | 250 | µL | In | ||||||||||||||
50 | COMBINEDBrain | 29FR 9457 | TBRS Community | Caucasian | Female | 11 | Tatton Brown Rahman Syndrome | c.2207G>A; p. R736H | DNMT3A | 10/13/2023 | CBB004202 0000 | 10/14/2023 | Plasma | 2.0 mL Cryovial | EDTA | 500 | µL | In | ||||||||||||||
51 | COMBINEDBrain | 29FR 9457 | TBRS Community | Caucasian | Female | 11 | Tatton Brown Rahman Syndrome | c.2207G>A; p. R736H | DNMT3A | 10/13/2023 | CBB004203 0000 | 10/14/2023 | Plasma | 2.0 mL Cryovial | EDTA | 500 | µL | In | ||||||||||||||
52 | COMBINEDBrain | 29FR 9457 | TBRS Community | Caucasian | Female | 11 | Tatton Brown Rahman Syndrome | c.2207G>A; p. R736H | DNMT3A | 10/13/2023 | CBB004205 0000 | 10/14/2023 | Plasma | 2.0 mL Cryovial | EDTA | 500 | µL | In | ||||||||||||||
54 | COMBINEDBrain | 29FR 9457 | TBRS Community | Caucasian | Female | 11 | Tatton Brown Rahman Syndrome | c.2207G>A; p. R736H | DNMT3A | 10/13/2023 | CBB004206 0000 | 10/14/2023 | Plasma | 2.0 mL Cryovial | EDTA | 500 | µL | In | ||||||||||||||
55 | COMBINEDBrain | 29FR 9457 | TBRS Community | Caucasian | Female | 11 | Tatton Brown Rahman Syndrome | c.2207G>A; p. R736H | DNMT3A | 10/13/2023 | CBB004207 0000 | 10/14/2023 | Plasma | 2.0 mL Cryovial | EDTA | 500 | µL | In | ||||||||||||||
56 | COMBINEDBrain | 29FR 9457 | TBRS Community | Caucasian | Female | 11 | Tatton Brown Rahman Syndrome | c.2207G>A; p. R736H | DNMT3A | 10/13/2023 | CBB004208 0000 | 10/14/2023 | Plasma | 2.0 mL Cryovial | EDTA | 500 | µL | In | ||||||||||||||
58 | COMBINEDBrain | 29FR 9457 | TBRS Community | Caucasian | Female | 11 | Tatton Brown Rahman Syndrome | c.2207G>A; p. R736H | DNMT3A | 10/13/2023 | CBB004210 0000 | 10/14/2023 | Plasma | 2.0 mL Cryovial | EDTA | 500 | µL | In | ||||||||||||||
59 | COMBINEDBrain | 29FR 9457 | TBRS Community | Caucasian | Female | 11 | Tatton Brown Rahman Syndrome | c.2207G>A; p. R736H | DNMT3A | 10/13/2023 | CBB004211 0000 | 10/14/2023 | Plasma | 2.0 mL Cryovial | EDTA | 100 | µL | In | ||||||||||||||
60 | COMBINEDBrain | 29FR 9457 | TBRS Community | Caucasian | Female | 11 | Tatton Brown Rahman Syndrome | c.2207G>A; p. R736H | DNMT3A | 10/13/2023 | CBB007048 0000 | 10/14/2023 | Urine | 2.0 mL Cryovial | 2000 | µL | In | |||||||||||||||
61 | COMBINEDBrain | 29FR 9457 | TBRS Community | Caucasian | Female | 11 | Tatton Brown Rahman Syndrome | c.2207G>A; p. R736H | DNMT3A | 10/13/2023 | CBB007049 0000 | 10/14/2023 | Urine | 2.0 mL Cryovial | 2000 | µL | In | |||||||||||||||
62 | COMBINEDBrain | 29FR 9457 | TBRS Community | Caucasian | Female | 12 | Tatton Brown Rahman Syndrome | c.2207G>A; p. R736H | DNMT3A | 5/26/2025 | CBB022193 0000 | 5/29/2025 | Nasal Cells | Nasal Swab Container | BuccalFix | 1 | ea | In | ||||||||||||||
63 | COMBINEDBrain | 29FR 9457 | TBRS Community | Caucasian | Female | 12 | Tatton Brown Rahman Syndrome | c.2207G>A; p. R736H | DNMT3A | 5/26/2025 | CBB022194 0000 | 5/29/2025 | Nasal Cells | Nasal Swab Container | BuccalFix | 1 | ea | In | ||||||||||||||
64 | COMBINEDBrain | 2CR4 REQ3 | TBRS Community | Female | 16 | Control | Sibling Control | DNMT3A | 03/19/2026 | AB035679 | 03/19/2026 | Plasma | K2/EDTA | 150 | ul | |||||||||||||||||
65 | COMBINEDBrain | 2CR4 REQ3 | TBRS Community | Female | 16 | Control | Sibling Control | DNMT3A | 03/19/2026 | AB035680 | 03/19/2026 | Plasma | K2/EDTA | 250 | ul | |||||||||||||||||
66 | COMBINEDBrain | 2CR4 REQ3 | TBRS Community | Female | 16 | Control | Sibling Control | DNMT3A | 03/19/2026 | AB035681 | 03/19/2026 | Plasma | K2/EDTA | 500 | ul | |||||||||||||||||
67 | COMBINEDBrain | 2CR4 REQ3 | TBRS Community | Female | 16 | Control | Sibling Control | DNMT3A | 03/19/2026 | AB035682 | 03/19/2026 | Plasma | K2/EDTA | 500 | ul | |||||||||||||||||
68 | COMBINEDBrain | 2CR4 REQ3 | TBRS Community | Female | 16 | Control | Sibling Control | DNMT3A | 03/19/2026 | AB035683 | 03/19/2026 | Plasma | K2/EDTA | 500 | ul | |||||||||||||||||
69 | COMBINEDBrain | 2CR4 REQ3 | TBRS Community | Female | 16 | Control | Sibling Control | DNMT3A | 03/19/2026 | AB035684 | 03/19/2026 | Plasma | K2/EDTA | 500 | ul | |||||||||||||||||
71 | COMBINEDBrain | 2CR4 REQ3 | TBRS Community | Female | 16 | Control | Sibling Control | DNMT3A | 03/19/2026 | AB035685 | 03/19/2026 | Plasma | K2/EDTA | 500 | ul | |||||||||||||||||
74 | COMBINEDBrain | 2CR4 REQ3 | TBRS Community | Female | 16 | Control | Sibling Control | DNMT3A | 03/19/2026 | AB035686 | 03/19/2026 | Plasma | K2/EDTA | 500 | ul | |||||||||||||||||
75 | COMBINEDBrain | 2CR4 REQ3 | TBRS Community | Female | 16 | Control | Sibling Control | DNMT3A | 03/19/2026 | AB035687 | 03/19/2026 | Plasma | K2/EDTA | 500 | ul | |||||||||||||||||
76 | COMBINEDBrain | 2CR4 REQ3 | TBRS Community | Female | 16 | Control | Sibling Control | DNMT3A | 03/19/2026 | AB035688 | 03/19/2026 | Plasma | K2/EDTA | 500 | ul | |||||||||||||||||
77 | COMBINEDBrain | 2CR4 REQ3 | TBRS Community | Female | 16 | Control | Sibling Control | DNMT3A | 03/19/2026 | AB034638 | 03/19/2026 | Whole Blood | K2/EDTA | 1000 | ul | |||||||||||||||||
78 | COMBINEDBrain | 2CR4 REQ3 | TBRS Community | Female | 16 | Control | Sibling Control | DNMT3A | 03/19/2026 | AB034639 | 03/19/2026 | Whole Blood | K2/EDTA | 1000 | ul | |||||||||||||||||
79 | COMBINEDBrain | 2CR4 REQ3 | TBRS Community | Female | 16 | Control | Sibling Control | DNMT3A | 03/19/2026 | AB034640 | 03/19/2026 | Whole Blood | K2/EDTA | 1000 | ul | |||||||||||||||||
80 | COMBINEDBrain | 2HXV ZAC2 | TBRS Community | Female | 11 | Tatton Brown Rahman Syndrome | c.2174-2A>G | DNMT3A | 4/13/2025 | CBB021700 0000 | 4/24/2025 | Whole Blood | Buccal Swab Container | EDTA | In | |||||||||||||||||
81 | COMBINEDBrain | 2HXV ZAC2 | TBRS Community | Female | 11 | Tatton Brown Rahman Syndrome | c.2174-2A>G | DNMT3A | 4/13/2025 | CBB021997 0000 | 4/24/2025 | Whole Blood | Buccal Swab Container | EDTA | In | |||||||||||||||||
82 | COMBINEDBrain | 2Z7M 4K73 | TBRS Community | Female | 46 | Control | Parent Control | DNMT3A | 4/13/2025 | CBB021713 0000 | 4/24/2025 | Whole Blood | Buccal Swab Container | EDTA | In | |||||||||||||||||
83 | COMBINEDBrain | 2Z7M 4K73 | TBRS Community | Female | 46 | Control | Parent Control | DNMT3A | 4/13/2025 | CBB022010 0000 | 4/24/2025 | Whole Blood | Buccal Swab Container | EDTA | In | |||||||||||||||||
87 | COMBINEDBrain | 3283 HSE0 | TBRS Community | Male | 26 | Tatton Brown Rahman Syndrome | c.928A>T; p. Ile310Phe | DNMT3A | 5/19/2025 | CBB022169 0000 | 5/27/2025 | Nasal Cells | 1.2 mL Cryovial | BuccalFix | 1 | ea | In | |||||||||||||||
88 | COMBINEDBrain | 39BJ SWU4 | TBRS Community | Female | 45 | Control | Parent Control | DNMT3A | 03/20/2026 | 56752507094466 | 03/20/2026 | Saliva | Stabilizing alcohol | 2 | mL | |||||||||||||||||
89 | COMBINEDBrain | 39YF CSAV | TBRS Community | Male | 44 | Control | Parent Control | DNMT3A | 03/20/2026 | 56752507094446 | 03/20/2026 | Saliva | Stabilizing alcohol | 2 | mL | |||||||||||||||||
90 | COMBINEDBrain | 3BS2 2X7S | TBRS Community | Female | 10 | Tatton Brown Rahman Syndrome | c.1661G>C; p.C554S | DNMT3A | 10/13/2023 | CBB004997 0000 | 10/14/2023 | Plasma | 2.0 mL Cryovial | EDTA | In | |||||||||||||||||
91 | COMBINEDBrain | 3BS2 2X7S | TBRS Community | Female | 10 | Tatton Brown Rahman Syndrome | c.1661G>C; p.C554S | DNMT3A | 10/13/2023 | CBB006910 0000 | 10/14/2023 | Blood Spot Card | 2.0 mL Cryovial | None | 2 | Blood Spot | In | |||||||||||||||
92 | COMBINEDBrain | 3BS2 2X7S | TBRS Community | Female | 10 | Tatton Brown Rahman Syndrome | c.1661G>C; p.C554S | DNMT3A | 10/13/2023 | CBB006949 0000 | 10/14/2023 | Plasma | 2.0 mL Cryovial | EDTA | 250 | µL | In | |||||||||||||||
93 | COMBINEDBrain | 3BS2 2X7S | TBRS Community | Female | 10 | Tatton Brown Rahman Syndrome | c.1661G>C; p.C554S | DNMT3A | 10/13/2023 | CBB006949 0100 | 7/24/2024 | Plasma | Matrix Plate Tube | EDTA | 55 | µL | In | |||||||||||||||
94 | COMBINEDBrain | 3BS2 2X7S | TBRS Community | Female | 10 | Tatton Brown Rahman Syndrome | c.1661G>C; p.C554S | DNMT3A | 10/13/2023 | CBB006950 0000 | 10/14/2023 | Plasma | 2.0 mL Cryovial | EDTA | 500 | µL | In | |||||||||||||||
95 | COMBINEDBrain | 3BS2 2X7S | TBRS Community | Female | 10 | Tatton Brown Rahman Syndrome | c.1661G>C; p.C554S | DNMT3A | 10/13/2023 | CBB006951 0000 | 10/14/2023 | Plasma | 2.0 mL Cryovial | EDTA | 500 | µL | In | |||||||||||||||
96 | COMBINEDBrain | 3BS2 2X7S | TBRS Community | Female | 10 | Tatton Brown Rahman Syndrome | c.1661G>C; p.C554S | DNMT3A | 10/13/2023 | CBB006952 0000 | 10/14/2023 | Plasma | 2.0 mL Cryovial | EDTA | 350 | µL | In | |||||||||||||||
97 | COMBINEDBrain | 3BS2 2X7S | TBRS Community | Female | 10 | Tatton Brown Rahman Syndrome | c.1661G>C; p.C554S | DNMT3A | 10/13/2023 | CBB007054 0000 | 10/14/2023 | Urine | 2.0 mL Cryovial | 2000 | µL | In | ||||||||||||||||
98 | COMBINEDBrain | 3BS2 2X7S | TBRS Community | Female | 10 | Tatton Brown Rahman Syndrome | c.1661G>C; p.C554S | DNMT3A | 10/13/2023 | CBB007055 0000 | 10/14/2023 | Urine | 2.0 mL Cryovial | 2000 | µL | In | ||||||||||||||||
99 | COMBINEDBrain | 3BS2 2X7S | TBRS Community | Female | 12 | Tatton Brown Rahman Syndrome | c.1661G>C; p.Cys554Ser | DNMT3A | 03/20/2026 | AB036068 | 03/20/2026 | Plasma | K2/EDTA | 150 | ul | |||||||||||||||||
100 | COMBINEDBrain | 3BS2 2X7S | TBRS Community | Female | 12 | Tatton Brown Rahman Syndrome | c.1661G>C; p.Cys554Ser | DNMT3A | 03/20/2026 | AB036069 | 03/20/2026 | Plasma | K2/EDTA | 250 | ul | |||||||||||||||||
101 | COMBINEDBrain | 3BS2 2X7S | TBRS Community | Female | 12 | Tatton Brown Rahman Syndrome | c.1661G>C; p.Cys554Ser | DNMT3A | 03/20/2026 | AB036070 | 03/20/2026 | Plasma | K2/EDTA | 500 | ul | |||||||||||||||||
102 | COMBINEDBrain | 3BS2 2X7S | TBRS Community | Female | 12 | Tatton Brown Rahman Syndrome | c.1661G>C; p.Cys554Ser | DNMT3A | 03/20/2026 | AB036071 | 03/20/2026 | Plasma | K2/EDTA | 500 | ul | |||||||||||||||||
103 | COMBINEDBrain | 3BS2 2X7S | TBRS Community | Female | 12 | Tatton Brown Rahman Syndrome | c.1661G>C; p.Cys554Ser | DNMT3A | 03/20/2026 | AB036072 | 03/20/2026 | Plasma | K2/EDTA | 500 | ul | |||||||||||||||||
104 | COMBINEDBrain | 3BS2 2X7S | TBRS Community | Female | 12 | Tatton Brown Rahman Syndrome | c.1661G>C; p.Cys554Ser | DNMT3A | 03/20/2026 | AB036073 | 03/20/2026 | Plasma | K2/EDTA | 500 | ul | |||||||||||||||||
105 | COMBINEDBrain | 3BS2 2X7S | TBRS Community | Female | 12 | Tatton Brown Rahman Syndrome | c.1661G>C; p.Cys554Ser | DNMT3A | 03/20/2026 | AB036074 | 03/20/2026 | Plasma | K2/EDTA | 500 | ul | |||||||||||||||||
106 | COMBINEDBrain | 3BS2 2X7S | TBRS Community | Female | 12 | Tatton Brown Rahman Syndrome | c.1661G>C; p.Cys554Ser | DNMT3A | 03/20/2026 | AB036075 | 03/20/2026 | Plasma | K2/EDTA | 500 | ul | |||||||||||||||||
107 | COMBINEDBrain | 3BS2 2X7S | TBRS Community | Female | 12 | Tatton Brown Rahman Syndrome | c.1661G>C; p.Cys554Ser | DNMT3A | 03/20/2026 | AB036076 | 03/20/2026 | Plasma | K2/EDTA | 500 | ul | |||||||||||||||||
108 | COMBINEDBrain | 3BS2 2X7S | TBRS Community | Female | 12 | Tatton Brown Rahman Syndrome | c.1661G>C; p.Cys554Ser | DNMT3A | 03/20/2026 | AB036077 | 03/20/2026 | Plasma | K2/EDTA | 500 | ul | |||||||||||||||||
109 | COMBINEDBrain | 3BS2 2X7S | TBRS Community | Female | 12 | Tatton Brown Rahman Syndrome | c.1661G>C; p.Cys554Ser | DNMT3A | 03/20/2026 | AB036078 | 03/20/2026 | Plasma | K2/EDTA | 500 | ul | |||||||||||||||||
110 | COMBINEDBrain | 3BS2 2X7S | TBRS Community | Female | 12 | Tatton Brown Rahman Syndrome | c.1661G>C; p.Cys554Ser | DNMT3A | 03/20/2026 | AB036079 | 03/20/2026 | Plasma | K2/EDTA | 500 | ul | |||||||||||||||||
111 | COMBINEDBrain | 3BS2 2X7S | TBRS Community | Female | 12 | Tatton Brown Rahman Syndrome | c.1661G>C; p.Cys554Ser | DNMT3A | 03/20/2026 | AB036080 | 03/20/2026 | Plasma | K2/EDTA | 500 | ul | |||||||||||||||||
112 | COMBINEDBrain | 3BS2 2X7S | TBRS Community | Female | 12 | Tatton Brown Rahman Syndrome | c.1661G>C; p.Cys554Ser | DNMT3A | 03/20/2026 | AB036081 | 03/20/2026 | Plasma | K2/EDTA | 500 | ul | |||||||||||||||||
114 | COMBINEDBrain | 3BS2 2X7S | TBRS Community | Female | 12 | Tatton Brown Rahman Syndrome | c.1661G>C; p.Cys554Ser | DNMT3A | 03/20/2026 | AB036031 | 03/20/2026 | Whole Blood | K2/EDTA | 1000 | ul |